Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

On what basis would this increase in 2 weeks, the earnings call? The stock has uncharacteristically been fairly stable after the last 2 calls the stock, unlike after prior earnings calls.

One of the major issues with this stock is the excessive outstanding shares. The company has been busy building a pipeline over the past couple of years after putting all their eggs in the SequestOx basket (that fell and cracked), but very little that has been done has been of financial benefit to the company. However, that pipeline is finally starting to be executed upon. New partnerships have been formed, new approvals leading to new launches (assuming Perc, Norco & Adderall are actually launched one day) in lieu of focusing on Trimipramine and Dantrolene.

Much of 2018 was setting up 2019. We’ll see if Elite can hit the ball on the tee. There is a ton of potential news in ‘19 and I believe this next cc sets the tone for how much of that will be positive news and how much will continue to be delayed yet again.